Study Shows, Lilly’s Covid-19 Antibody Drugs Effective at Lower Doses

Photo credits:

Two Eli Lilly & Co. antibody-based drugs reduced Covid-19-related hospitalizations and deaths among recently diagnosed patients when given at lower doses than previously tested, a new study found,

Visit the link to check the full article right here.